Back
COHEN & STEERS QUALITY INCOME REALTY FUND Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
47
RQI
COHEN & STEERS QUALITY INCOME REALTY FUND
Last Price:
13.95
Seasonality Move:
-5.21%
Sell
22
APLS
Apellis Pharmaceuticals
Last Price:
32.71
Seasonality Move:
18.8%
Sell
47
COHEN & STEERS QUALITY INCOME REALTY FUND (RQI)
is a Sell
Is COHEN & STEERS QUALITY INCOME REALTY FUND a Buy, Sell or Hold?
- The current COHEN & STEERS QUALITY INCOME REALTY FUND [RQI] share price is $13.99. The Score for RQI is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RQI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $32.72. The Score for APLS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RQI Stock Price Chart
What is COHEN & STEERS QUALITY INCOME REALTY FUND's stock price today?
-
The COHEN & STEERS QUALITY INCOME REALTY FUND share price today is $13.99
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RQI is experiencing buying pressure, which is a positive indicator for future bullish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $32.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
RQI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.29 | Buy |
Relative Strength Index (14 RSI): | 63.06 | Buy |
Chaikin Money Flow: | 254994 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.23 - 14.05) | Buy |
Bollinger Bands (100): | (11.33 - 13.19) | Buy |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.09 | Sell |
Relative Strength Index (14 RSI): | 34.53 | Sell |
Chaikin Money Flow: | 2311416 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.9 - 40.1) | Sell |
Bollinger Bands (100): | (36.41 - 42.27) | Sell |
RQI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.02 | Sell |
20-day SMA: | 13.8 | Buy |
50-day SMA: | 13.04 | Buy |
200-day SMA: | 11.99 | Buy |
8-day EMA: | 13.94 | Buy |
20-day EMA: | 13.73 | Buy |
50-day EMA: | 13.15 | Buy |
200-day EMA: | 12.14 | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.48 | Sell |
20-day SMA: | 37.67 | Sell |
50-day SMA: | 37.75 | Sell |
200-day SMA: | 49.84 | Sell |
8-day EMA: | 35.24 | Sell |
20-day EMA: | 36.78 | Sell |
50-day EMA: | 38.03 | Sell |
200-day EMA: | 45.57 | Sell |
COHEN & STEERS QUALITY INCOME REALTY FUND Earnings Growth & RQI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.32 per share.
COHEN & STEERS QUALITY INCOME REALTY FUND Technical Analysis
Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |